Cleveland Clinic Phases Out Cancer-Sniffing Leopard Program

Administrators at the Cleveland Clinic announced on Tuesday the decision to cease utilizing a leopard in clinical cancer screenings. The move comes after the perceived benefits of the animal's detection abilities were overshadowed by significant operational issues.

Hospital CEO Tomislav Mihaljevic stated that while the leopard's accuracy in identifying cancer had been remarkable, the program was being phased out. This decision followed "extensive" complaints lodged by patients and their families.

Diagnostic Methods Deemed Too Invasive

Mihaljevic acknowledged Fang’s unparalleled skill in locating malignant tumors. However, he noted that the leopard frequently employed "deeply invasive maulings and eviscerations" as part of its diagnostic routine.

The CEO cited a recent, severe incident involving a nine-year-old leukemia patient. This patient suffered a disembowelment, although Mihaljevic pointed out that this event did allow for verification of cancer spread to the liver.

Shift Back to Traditional Testing

Due to these severe complications, the clinic's medical staff has been directed to revert to conventional methods for cancer testing. The hospital is now re-evaluating other unconventional programs in light of these events.

Specifically, Mihaljevic reported that the facility is also reconsidering its ongoing therapy piranha program. The clinic is focusing on ensuring patient safety moving forward.